Currently, innovative development that incorporates continuous glucose monitors into insulin pumps achieved algorithm‐driven automation of insulin delivery, which results in a significant reduction in the morbidity and mortality of DM.8, 9, 10. The gene discussed is INS; the disease is diabetes mellitus.